1-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl-1H-pyrazole, 99.0%, 500g

(4S,4'S)-4,4'-Di((S)-sec-butyl)-1,1'-bis(3-(tert-butyl)phenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

(8E,10E)-Dodecadien-1-ol, 90%, 100mg

Matraces de fondo redondo de tres bocas, bocas laterales, biselados, 3000 ml, 29/32, 14/23, 1 unidad

(4-Chlorothieno[3,2-d]pyrimidin-7-yl)methanol, 98%, 250mg

4-Sulfamicphenylhydrazine hydrochloride, 97.0%, 5g

7H-PURINE-7-ACETAMIDE, 1,2,3,6-TETRAHYDRO-1,3-DIMETHYL-2,6-DIOXO-N-(6-PHENYL-3-PYRIDAZINYL)-, 98%, 10mg

4-Oxoheptanedioic acid, 95%, 5g

Barras agitadoras magnéticas ROTILABO® con anillo central, , 8 mm, 13 mm, amarillo, 1 unidad

1,4-DIBROMO-2,3-DIFLUORO-5,6-DINITROBENZENE, 96%, 1g

Methyl 4-bromo-2-formylbenzoate, 97%, 5g

4-Benzylmorpholin-2-one, 95.0%, 100mg

(-)-2,2`-((1S,2S)-1,2-DIAMINOETHANE-1,2-DIYL)-DIPHENOL, 97.0%, 5g